EP4568664
COMBINATION COMPRISING A THR-BETA AGONIST AND A GLP-1R AGONIST FOR USE IN TREATING OBESITY
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
8.4.2024EP published:
1.4.2026EP application number:
24724715.8
EPO information:
European Patent Register
Max expiry date:
7.4.2044Expiry date:
31.7.2026
Title in English:
COMBINATION COMPRISING A THR-BETA AGONIST AND A GLP-1R AGONIST FOR USE IN TREATING OBESITYLanguage of the patent:
English
Timeline
Today
8.4.2024EP application
1.4.2026EP Publication
31.7.2026Expires
Owner
Name:
Terns Pharmaceuticals, Inc.Address:
1065 East Hillsdale Blvd. Suite 100, Foster City, California 94404, US
Inventor
Name:
TEAL, Olivia D.Address:
Foster City, California 94404, US
Name:
QUINN, Kevin P.Address:
Foster City, California 94404, US
Name:
JONES, Christopher T.Address:
Foster City, California 94404, US
Name:
JASPER, Jeffrey R.Address:
Foster City, California 94404, US
Priority
Number:
202363495049 PDate:
7.4.2023Country:
US
Number:
202363526362 PDate:
12.7.2023Country:
US
Number:
202363615985 PDate:
29.12.2023Country:
US
Classification
Categories:
A61K 31/351, A61K 31/4166, A61K 31/4184, A61K 31/4245, A61K 31/427, A61K 31/53, A61K 38/17, A61K 45/06, A61P 1/16, A61P 3/04, A61K 38/26